• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Membranoproliferative glomerulonephritis: the Cincinnati experience--cumulative renal survival from 1957 to 1989.

作者信息

McEnery P T

机构信息

Children's Hospital Research Foundation, Cincinnati, OH 45229-2899.

出版信息

J Pediatr. 1990 May;116(5):S109-14. doi: 10.1016/s0022-3476(05)82712-x.

DOI:10.1016/s0022-3476(05)82712-x
PMID:2329412
Abstract

Seventy-six children with idiopathic MPGN have been followed at this medical center since 1957 (mean 10.6 years of disease). Seventy-one of the children have been treated with a regimen of prednisone (mean 7.7 years of treatment). Monotherapy with alternate-day prednisone was used in 50 of the children. Other immunosuppressive and cytotoxic drugs have not been used since 1981. In the 71 treated patients, the cumulative renal survival (creatinine less than 3.0 mg/dl (265.5 mumol/L)) was 82% in the tenth year and 56% in the twentieth year after disease onset. Cumulative renal survival, calculated from the date of initiation of the prednisone regimen, was 75% in the tenth year and 59% in the twentieth year. As our experience with this disease has increased, long-term cumulative renal survival has improved.

摘要

相似文献

1
Membranoproliferative glomerulonephritis: the Cincinnati experience--cumulative renal survival from 1957 to 1989.
J Pediatr. 1990 May;116(5):S109-14. doi: 10.1016/s0022-3476(05)82712-x.
2
Differences between membranoproliferative glomerulonephritis types I and III in long-term response to an alternate-day prednisone regimen.I型和III型膜增生性肾小球肾炎对隔日泼尼松治疗方案的长期反应差异。
Am J Kidney Dis. 1999 Dec;34(6):1022-32. doi: 10.1016/S0272-6386(99)70007-7.
3
Immunosuppressive treatment of membranoproliferative glomerulonephritis.膜增生性肾小球肾炎的免疫抑制治疗
Nephron. 1994;67(1):59-65. doi: 10.1159/000187889.
4
Non-nephrotic children with membranoproliferative glomerulonephritis: are steroids indicated?患有膜增生性肾小球肾炎的非肾病患儿:是否需要使用类固醇药物?
Pediatr Nephrol. 1995 Apr;9(2):140-4. doi: 10.1007/BF00860727.
5
The effect of prednisone in a high-dose, alternate-day regimen on the natural history of idiopathic membranoproliferative glomerulonephritis.高剂量隔日疗法的泼尼松对特发性膜增生性肾小球肾炎自然病程的影响。
Medicine (Baltimore). 1985 Nov;64(6):401-24. doi: 10.1097/00005792-198511000-00005.
6
Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.系膜病变所致肾病综合征的免疫抑制治疗
Clin Nephrol. 1996 Oct;46(4):237-44.
7
Response of type I membranoproliferative glomerulonephritis to pulse methylprednisolone and alternate-day prednisone therapy.I型膜增生性肾小球肾炎对甲泼尼龙冲击及隔日泼尼松治疗的反应
Pediatr Nephrol. 1995 Jun;9(3):268-71. doi: 10.1007/BF02254181.
8
Childhood membranoproliferative glomerulonephritis type I: limited steroid therapy.儿童I型膜增生性肾小球肾炎:有限疗程的类固醇治疗。
Kidney Int. 1992 Jun;41(6):1606-12. doi: 10.1038/ki.1992.232.
9
Rapidly deteriorating renal function with membranoproliferative glomerulonephritis Type 1 associated with hepatitis C treated successfully with steroids and antiviral therapy: a case report and review of literature.1型膜增生性肾小球肾炎合并丙型肝炎导致肾功能迅速恶化,经类固醇和抗病毒治疗成功:病例报告及文献复习
Clin Nephrol. 2008 Apr;69(4):298-301. doi: 10.5414/cnp69298.
10
Membranoproliferative glomerulonephritis: improved survival with alternate day prednisone therapy.膜增生性肾小球肾炎:隔日泼尼松治疗可提高生存率。
Clin Nephrol. 1980 Mar;13(3):117-24.

引用本文的文献

1
Cyclosporine therapy could be considered for membranoproliferative glomerulonephritis with immunoglobulin A deposits: a case report.环孢素治疗免疫球蛋白 A 沉积的膜增生性肾小球肾炎:病例报告。
BMC Nephrol. 2022 Nov 7;23(1):358. doi: 10.1186/s12882-022-02983-5.
2
Outcome of patients with primary immune-complex type mesangiocapillary glomerulonephritis (MCGN) in Cape Town South Africa.南非开普敦原发性免疫复合物型系膜毛细血管性肾小球肾炎(MCGN)患者的治疗结果
PLoS One. 2014 Nov 20;9(11):e113302. doi: 10.1371/journal.pone.0113302. eCollection 2014.
3
Chapter 8: Idiopathic membranoproliferative glomerulonephritis.
第8章:特发性膜增生性肾小球肾炎。
Kidney Int Suppl (2011). 2012 Jun;2(2):198-199. doi: 10.1038/kisup.2012.21.
4
C3 nephritic factor associated with C3 glomerulopathy in children.与儿童C3肾小球病相关的C3肾炎因子
Pediatr Nephrol. 2014 Jan;29(1):85-94. doi: 10.1007/s00467-013-2605-6. Epub 2013 Sep 26.
5
Allelic variants of complement genes associated with dense deposit disease.与密性层状营养不良相关的补体基因的等位基因变异。
J Am Soc Nephrol. 2011 Aug;22(8):1551-9. doi: 10.1681/ASN.2010080795. Epub 2011 Jul 22.
6
Prognostic factors in children with membranoproliferative glomerulonephritis type I.I型膜增生性肾小球肾炎患儿的预后因素
Pediatr Nephrol. 2008 Jun;23(6):929-35. doi: 10.1007/s00467-008-0754-9.
7
Transition of children with membranoproliferative glomerulonephritis to adolescence and adulthood.膜增生性肾小球肾炎患儿向青春期及成年期的转变。
Clin Exp Nephrol. 2008 Feb;12(1):28-32. doi: 10.1007/s10157-007-0014-5. Epub 2008 Jan 5.
8
Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease).补体调节基因H因子(CFH)和H因子相关蛋白5(CFHR5)的变异与II型膜增生性肾小球肾炎(致密物沉积病)相关。
J Med Genet. 2006 Jul;43(7):582-9. doi: 10.1136/jmg.2005.038315. Epub 2005 Nov 18.
9
Long-term follow-up of atypical membranoproliferative glomerulonephritis: are steroids indicated?非典型膜增生性肾小球肾炎的长期随访:是否需要使用类固醇?
Pediatr Nephrol. 2006 Feb;21(2):194-200. doi: 10.1007/s00467-005-2074-7. Epub 2005 Oct 25.
10
Long-term follow-up of diffuse membranoproliferative glomerulonephritis type I.I型弥漫性膜增生性肾小球肾炎的长期随访
Pediatr Nephrol. 2005 May;20(5):585-90. doi: 10.1007/s00467-005-1826-8. Epub 2005 Mar 22.